Credit: By Neil Brake, Vanderbilt University

NanoMedicine Events

If you would like your event listed here, please contact Tiju Joseph.

One-day Course : “What is nanomedicine?”
Tuesday 27 November 2007

The Institute of Nanotechnology (IoN) and Cranfield University are pleased to announce a one-day training course “What is nanomedicine?” to be held on Tuesday 27 November 2007 from 10h00 – 17h00 at the Linnean Society of London, Burlington House, Piccadilly, London W1J 0BF.

Nanotechnology is defined as the “design, characterisation, production and application of structures, devices and systems by controlling shape and size at the nanoscale (having one or more dimensions of the order of 100 nm or less)”. One of the most active and important current areas of research and application of nanotechnology is in the field of medicine. Many industry and business analysts now expect nanotechnology to revolutionise the pharmaceutical, medical devices, diagnostics and imaging sectors with annual markets of billions of pounds likely within five years.

This course is the first in a number of short professional training modules in the field of nanomedicine being prepared jointly by the IoN, the acknowledged leaders in nanotechnology information in Europe and Cranfield University, the UK’s leading postgraduate university and a leader in the provision of short professional courses. It has been designed to provide practising clinicians, researchers and industry specialists with a broad overview of the main topics, areas of research and issues within nanomedicine.

The course will be presented by:
Professor Shervanthi Homer-Vanniasinkam (Consultant Vascular Surgeon at Leeds General Infirmary, Clinical Sub-Dean of Leeds University Medical School and Professor of Translational Vascular Medicine at the University of Bradford),
Professor Tony Turner (Distinguished Professor of Biotechnology and Professor of Biosensor Technology at Cranfield University)
Richard Moore (Manager of Nanomedicine and Lifesciences at the Institute of Nanotechnology).

Places on the course are limited in order to provide an interactive learning environment and early booking is therefore recommended. Prices (including course materials, lunch and refreshments) are:

Practising clinicians and academic researchers: £250

Industry representatives: £400

To reserve a place please contact [email protected]
Tel: 01786 447520 / Fax: 01786 447 530.
Payment may be made online at : www.nano.org.uk/payments/

Annual Nanomednet Event:

Investing in Medical Nanotechnologies II
28-29 November 2007: Royal College of Surgeons of England, London, UK

The conference will showcase cutting edge technologies in personalized medicine, targeted drug delivery, nanobiomaterials, regenerative medicine, analytical and diagnostic techniques, body-friendly implants, imaging techniques, treatments for degenerative diseases, cures for diseases for the aging population, functionalised nanoparticles, and converging technologies for healthcare applications.

Details: http://nanomedsnet.com/conference07/index.htm

Public Debate: Nanomedicine… hype? Or a real revolution in healthcare?, Royal College of Surgeons from 18h30 – 20h30, 28 November 2007

Institute of Nanotechnology , a global leader in nanotechnology information services is organising a public engagement evening ‘ Nanomedicine…hype? Or a real revolution in healthcare?’ on the 28 th of November at the Royal College of Surgeons of London. This free event offers an opportunity to the general public to share their thoughts with industrial leaders, nanotechnologists and politicians.

Chaired by Geoff Watts, eminent writer and broadcaster on science and medicine and currently the p resenter of the BBC Radio 4 ‘Leading Edge’ programme, the panel members who will lead the discussions include Dr. Doug Naysmith, MP, Bristol North West , Dr. Leonard Fass, Director of Academic Relations, GE Healthcare, Mr. Michael Lussier, General Manager, Volcano Corporation, Prof. Shervanthi Homer-Vanniasinkam, Consultant Vascular Surgeon, Leeds General Infirmary; Clinical Sub-Dean, Leeds University Medical School and Dr. Marisa Papaluca Amati, Deputy Head of Sector, European Medicines Agency (EMEA).

In the interest of openness and public engagement this panel discussion and public debate, which will be held at the Royal College of Surgeons from 18h30 – 20h30 on 28 November 2007, is open to all and is free. Places are limited and, therefore, early registration is recommended. For more information and registration, visit: http://www.nano.org.uk/events/ionevents.htm or contact Tiju Joseph, [email protected], 0141 330 8734